GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dingdang Health Technology Group Ltd (HKSE:09886) » Definitions » Peter Lynch Fair Value

Dingdang Health Technology Group (HKSE:09886) Peter Lynch Fair Value : HK$-5.38 (As of May. 27, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Dingdang Health Technology Group Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Dingdang Health Technology Group's PEG is 1. Dingdang Health Technology Group's 5-Year TTM EBITDA Growth Rate is 16.05. Dingdang Health Technology Group's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.34. Therefore, the Peter Lynch Fair Value for today is HK$-5.38.

As of today (2025-05-27), Dingdang Health Technology Group's share price is HK$0.435. Dingdang Health Technology Group's Peter Lynch fair value is HK$-5.38. Therefore, Dingdang Health Technology Group's Price to Peter Lynch Fair Value Ratio for today is N/A.


The historical rank and industry rank for Dingdang Health Technology Group's Peter Lynch Fair Value or its related term are showing as below:



HKSE:09886's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.575
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Dingdang Health Technology Group Peter Lynch Fair Value Historical Data

The historical data trend for Dingdang Health Technology Group's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dingdang Health Technology Group Peter Lynch Fair Value Chart

Dingdang Health Technology Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Dingdang Health Technology Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dingdang Health Technology Group's Peter Lynch Fair Value

For the Health Information Services subindustry, Dingdang Health Technology Group's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dingdang Health Technology Group's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Dingdang Health Technology Group's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Dingdang Health Technology Group Peter Lynch Fair Value Calculation

Dingdang Health Technology Group's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 16.05 *-0.335
=-5.38

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dingdang Health Technology Group's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.34.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Dingdang Health Technology Group  (HKSE:09886) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 16.05 instead of 15 in this case.

Dingdang Health Technology Group's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.435/-5.38
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dingdang Health Technology Group Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Dingdang Health Technology Group's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Dingdang Health Technology Group Business Description

Traded in Other Exchanges
N/A
Address
Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Executives
Shen Zhen Zhao Yin Dian Xin Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shen Zhen Zhao Yin Dian Xin Xin Qu Shi Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Guang Zhou Shi Zhao Xin Wu Ji Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Shan Hai Yi Hao Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Yang Xiao
Yang Yibin
Yang Wenlong
Chuang Ji Tou Zi You Xian Gong Si
Zhi Sheng Qi Ye You Xian Gong Si
Jin Fa You Xian Gong Si
Jian Fa You Xian Gong Si
Zhi Ying Ji Tuan You Xian Gong Si
Jian Xing You Xian Gong Si
Xing Xin You Xian Gong Si

Dingdang Health Technology Group Headlines

No Headlines